Company news
Citius Oncology, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Citius Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
September 4, 2024
Citius Pharmaceuticals Completes Merger of Subsidiary with TenX Keane to form Citius Oncology, Inc.
August 11, 2024
TenX Keane Acquisition Addresses Trading Halt, Continues Towards Closing of Business Combination, and Provides Market Update
August 8, 2024
TenX Keane Acquisition Shareholders Approve Previously Announced Merger to Form Citius Oncology, Inc., a Publicly Listed Subsidiary of Citius Pharmaceuticals
August 4, 2024
Citius Pharmaceuticals Announces TenX Keane Shareholder Approval of Merger with Citius Oncology, Inc.
August 4, 2024
TenX Keane Acquisition Announces Contribution to Trust Account in Connection with Extension Amendment Proposal
January 9, 2024
Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.
October 23, 2023
TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business Combination
July 17, 2023
Decks
- Investor Presentation (December 2025)
Investor deck · 19 slides · Dec 1, 2025
- Investor Presentation (October 2025)
Investor deck · 19 slides · Oct 23, 2025
- SPAC Merger (October 2023)
SPAC merger · 33 slides · Oct 24, 2023